Changjin Lim

444 total citations
48 papers, 309 citations indexed

About

Changjin Lim is a scholar working on Molecular Biology, Organic Chemistry and Cancer Research. According to data from OpenAlex, Changjin Lim has authored 48 papers receiving a total of 309 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 13 papers in Organic Chemistry and 8 papers in Cancer Research. Recurrent topics in Changjin Lim's work include Synthetic Organic Chemistry Methods (6 papers), Breast Cancer Treatment Studies (5 papers) and Microbial Natural Products and Biosynthesis (4 papers). Changjin Lim is often cited by papers focused on Synthetic Organic Chemistry Methods (6 papers), Breast Cancer Treatment Studies (5 papers) and Microbial Natural Products and Biosynthesis (4 papers). Changjin Lim collaborates with scholars based in South Korea, Sudan and United States. Changjin Lim's co-authors include Young‐Ger Suh, Seok‐Ho Kim, Kiwon Jung, Jaehoon Sim, Z. G. Khim, S. Lee, Byoung Jin Suh, Jhinhwan Lee, Sun‐Young Moon and Hongchan An and has published in prestigious journals such as Angewandte Chemie International Edition, Physical review. B, Condensed matter and Chemical Communications.

In The Last Decade

Changjin Lim

43 papers receiving 304 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Changjin Lim South Korea 9 105 72 42 33 32 48 309
Tadashi Kobayashi Japan 11 91 0.9× 66 0.9× 38 0.9× 14 0.4× 23 0.7× 27 359
M. Carmen de la Fuente Spain 13 237 2.3× 321 4.5× 34 0.8× 3 0.1× 20 0.6× 25 435
A. Takeda Japan 12 76 0.7× 102 1.4× 15 0.4× 11 0.3× 4 0.1× 32 360
Sean M. Lynn United Kingdom 13 228 2.2× 121 1.7× 38 0.9× 18 0.6× 28 450
Fábio Luiz Paranhos Costa Brazil 9 143 1.4× 69 1.0× 22 0.5× 3 0.1× 5 0.2× 39 409
Hongmin Liu China 9 227 2.2× 55 0.8× 22 0.5× 19 0.6× 1 0.0× 31 389
Paul Ortiz de Montellano United States 14 311 3.0× 51 0.7× 18 0.4× 2 0.1× 82 2.6× 17 622
Maxim Gureev Russia 11 138 1.3× 137 1.9× 37 0.9× 7 0.2× 48 368
Debnath Bhuniya India 17 173 1.6× 521 7.2× 67 1.6× 34 1.1× 38 649
Catherine Fontaine France 16 228 2.2× 164 2.3× 48 1.1× 1 0.0× 11 0.3× 31 499

Countries citing papers authored by Changjin Lim

Since Specialization
Citations

This map shows the geographic impact of Changjin Lim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Changjin Lim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Changjin Lim more than expected).

Fields of papers citing papers by Changjin Lim

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Changjin Lim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Changjin Lim. The network helps show where Changjin Lim may publish in the future.

Co-authorship network of co-authors of Changjin Lim

This figure shows the co-authorship network connecting the top 25 collaborators of Changjin Lim. A scholar is included among the top collaborators of Changjin Lim based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Changjin Lim. Changjin Lim is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Han, Young‐Min, Sun‐Mi Yun, Da-Young Lee, et al.. (2025). Targeting KEAP1-mediated IKKβ degradation strategy for colitis-associated colorectal carcinogenesis: The potential of xanthohumol. Biomedicine & Pharmacotherapy. 184. 117879–117879.
2.
Chen, Si, Mi‐Young Song, Changjin Lim, et al.. (2025). Cannabidiol reshapes the gut microbiome to promote endurance exercise in mice. Experimental & Molecular Medicine. 57(2). 489–500. 2 indexed citations
3.
Lim, Changjin, et al.. (2024). Investigation of the Storage and Stability as Well as the Dissolution Rate of Novel Ilaprazole/Xylitol Cocrystal. Pharmaceutics. 16(1). 122–122. 2 indexed citations
4.
Lim, Changjin, Chi Heung Cho, Sang Gil Lee, et al.. (2024). Efficient biotransformation of naringenin to naringenin α-glucoside, a novel α-glucosidase inhibitor, by amylosucrase from Deinococcus wulumuquiensis. Food Chemistry. 448. 139182–139182. 2 indexed citations
5.
Kang, Eunhye, Changjin Lim, Hong Kyu Kim, et al.. (2024). Increased risk of contralateral breast cancer for BRCA1/2 wild-type, high-risk Korean breast cancer patients: a retrospective cohort study. Breast Cancer Research. 26(1). 14–14. 4 indexed citations
6.
7.
Kim, Hyun Su, Taewoo Kim, Changjin Lim, et al.. (2023). Structural Congeners of Izenamides Responsible for Cathepsin D Inhibition: Insights from Synthesis-Derived Elucidation. Marine Drugs. 21(5). 281–281. 1 indexed citations
8.
Kim, Eun‐Kyu, Eunyoung Kang, Jee Hyun Kim, et al.. (2023). Development and External Validation of a Machine Learning Model to Predict Pathological Complete Response After Neoadjuvant Chemotherapy in Breast Cancer. Journal of Breast Cancer. 26(4). 353–353. 3 indexed citations
9.
Kim, Hong‐Kyu, et al.. (2022). The usefulness of a three-protein signature blood assay (Mastocheck®) for follow-up after breast cancer surgery. Journal of Cancer Research and Clinical Oncology. 149(9). 5733–5741.
10.
Kim, Taewoo, Hyun Su Kim, Juhee Lim, et al.. (2022). Discovery of new ERRγ agonists regulating dopaminergic neuronal phenotype in SH-SY5Y cells. Bioorganic Chemistry. 122. 105716–105716. 3 indexed citations
11.
Lim, Changjin, Jeong‐Moo Lee, Eui Soo Han, et al.. (2021). Clinical usefulness of T1-weighted MR cholangiography with Gd-EOB-DTPA for the evaluation of biliary complication after liver transplantation. Annals of Hepato-Biliary-Pancreatic Surgery. 25(1). 39–45. 3 indexed citations
12.
Kim, Taewoo, Da-Young Lee, Dong‐Jun Kim, et al.. (2021). Concise syntheses and anti-inflammatory effects of isocorniculatolide B and corniculatolide B and C. Bioorganic Chemistry. 116. 105398–105398. 2 indexed citations
13.
Song, Moon-Young, Changjin Lim, Young‐Ger Suh, et al.. (2020). Efficient and Divergent Enantioselective Syntheses of DHPVs and Anti-Inflammatory Effect on IEC-6 Cells. Molecules. 25(9). 2215–2215. 8 indexed citations
14.
Yoon, Jeong Ae, Changjin Lim, & Young Taek Han. (2020). Preliminary Study on Novel Expedient Synthesis of 5-Azaisocoumarins by Transition Metal-Catalyzed Cycloisomerization. Frontiers in Chemistry. 8. 772–772. 4 indexed citations
15.
Hong, Shin Hee, YoungJoon Park, Jong-Hyuk Sung, et al.. (2019). MD001, a Novel Peroxisome Proliferator-activated Receptor α/γ Agonist, Improves Glucose and Lipid Metabolism. Scientific Reports. 9(1). 1656–1656. 18 indexed citations
16.
Jang, Hye‐Jeong, In-Young Chung, Changjin Lim, et al.. (2019). Redirecting an Anticancer to an Antibacterial Hit Against Methicillin-Resistant Staphylococcus aureus. Frontiers in Microbiology. 10. 350–350. 17 indexed citations
17.
Yoon, Hojong, Changjin Lim, Jaebong Jang, et al.. (2018). Asymmetric Synthesis of (−)-6-Desmethyl-Fluvirucinine A1 via Conformationally-Controlled Diastereoselective Lactam-Ring Expansions. Molecules. 23(9). 2351–2351. 2 indexed citations
18.
Suh, Young‐Ger, Changjin Lim, Jaehoon Sim, et al.. (2017). Construction of the Azacyclic Core of Tabernaemontanine-Related AlkaloidsviaTandem Reformatsky–Aza-Claisen Rearrangement. The Journal of Organic Chemistry. 82(3). 1464–1470. 8 indexed citations
19.
Lim, Changjin, Jaehoon Sim, Hwayoung Yun, et al.. (2017). Total synthesis of (+)-brasilenyne via concise construction of an oxonane framework containing a 1,3-cis,cis-diene. Chemical Communications. 54(5). 467–470. 5 indexed citations
20.
Kim, Nam‐Jung, Kyeojin Kim, Young Taek Han, et al.. (2012). Novel human umbilical vein endothelial cells (HUVEC)-apoptosis inhibitory phytosterol analogues: Insight into their structure-activity relationships. Archives of Pharmacal Research. 35(3). 455–460. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tadashi Kobayashi Breakdown of academic impact, for papers by M. Carmen de la Fuente Breakdown of academic impact, for papers by A. Takeda Breakdown of academic impact, for papers by Sean M. Lynn Breakdown of academic impact, for papers by Fábio Luiz Paranhos Costa Breakdown of academic impact, for papers by Hongmin Liu Breakdown of academic impact, for papers by Paul Ortiz de Montellano Breakdown of academic impact, for papers by Maxim Gureev Breakdown of academic impact, for papers by Debnath Bhuniya Breakdown of academic impact, for papers by Catherine Fontaine
Rankless by CCL
2026